The global burden of rheumatic heart disease continues to be significant although it is
largely limited to poor and marginalized populations. In most endemic regions, affected …

Background Six billion people in low-and middle-income countries (LMICs) lack timely or
ready access to safe and affordable cardiac surgical care when needed, which remains a …

Objective Cardiovascular disease is the leading cause of death worldwide, responsible for
17.5 million deaths every year, of which 80% occur in low-and middle-income countries …

Global Variations in Heart Failure Etiology, Management, and Outcomes - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

More than 6 billion people live outside industrialized countries and have insufficient access
to cardiac surgery. Given the recently confirmed high prevailing mortality for rheumatic heart …

Rheumatic heart valve disease (RHVD) is a post-infectious sequel of acute rheumatic fever
resulting from an abnormal immune response to a streptococcal pharyngitis that triggers …

Abstract Coronavirus diseases 2019 (COVID-19) has become a worldwide pandemic
affecting people at high risk and particularly at advanced age, cardiovascular and …

In situ tissue engineering using bioresorbable material implants-or scaffolds-that harness
the patient's immune response while guiding neotissue formation at the site of implantation …

Although entirely preventable, rheumatic heart disease (RHD), a disease of poverty and
social disadvantage resulting in high morbidity and mortality, remains an ever-present …

Rheumatic heart disease (RHD) is the only preventable cardiovascular disease which
causes significant morbidity and mortality particularly in low-and middle-income countries …